Allied Market Research


Desynchronosis Treatment Market

Desynchronosis Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product and, by Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Since inception of commercial and defense-related air travel, there has been constant increase in the number of people travelling on international tours. In addition, globalization has fueled the idea of global village with higher rate of people travelling to different countries for travel, work purpose, and formal trade relations. A common complaint associated with frequent air travel is “jet lag.” It results from body’s inability to readjust to rapid changes in time and external macroenvironment. This results in increased fatigue, decreased energy levels, and distorted body metabolism. Over the years, various advanced therapeutics have been deployed, as portable treatment options for jet lag, including intermittent sleeping patterns and use of melatonin.

COVID-19 Impact Analysis

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global desynchronosis treatment market.

Top Impacting Factors

  • Exponential in the number of air travel each year disrupts sleep patterns, body metabolism, and gastro intestinal tract resulting in alterations of body clock also known as circadian rhythms. This, in turn, has paved way for easy and quick treatment therapeutics to treat jet lags.
  • Rise in globalization, influx of global trade, supply chain widening, globalized planned migrations and the growing idea of one globalized village resulting in frequent air travels across continents and regions drive the demand for desynchronosis treatment.
  • Advantages associated with deploying easy-to-use portable wearable technologies to monitor cardiovascular patterns especially in regions with high disposable income and better skilled personnel support for the growth of the desynchronosis treatment market.
  • However, cases of drug addictions attached with the use of these advanced therapeutics to treat jet lags. Among these, addictions attached to melatonin are the most frequent ones that might hamper market growth.
  • Additionally, less purchasing power parity and low awareness regarding new age portable wearable technologies in underdeveloped nations might hamper market penetration into these areas.

Key Market Trends

  • North America is anticipated to gain significant market traction, owing increased use of melatonin as a viable solution against desynchronosis. In addition, the region holds highest number of regional and global manufacturers, thus providing them with an array of frequent product trials, etc.
  • Researchers are working on the possibility of curing jet lags through barefoot grass walking technique. Under this, the patients are to be advised to walk over clean, natural grass barefoot for a stipulated time. The technique under initial trails has shown great psychological results by balancing the sleep pattern and body metabolism trade off.
  • Neuroon is a revolutionary and utterly successful device that was established as a possible countermeasure against jet lags. The device incorporates advanced brain wave and pulse measurement mechanisms to improve sleep patterns. It further uses biometric sensors to study person’s sleep architecture and offer sleep optimization routine.
  • Recently, light therapy has come under intense consideration as a viable jet lag treatment alternative. The mechanism is employed to at night to speed up brain’s adjustments toward time changes with the help of a technique known as “biological hacking.”
  • Use of hypnotics has been proposed to balance the tradeoff between sleep cycle and time changes.
  • Triazolam, an advanced therapeutic drug, has been see to block jet lag effects in early clinical trials thus realigning the circadian cycles. However, the efficacy of the drug at a larger level is still highly questionable.
  • NASA studies have proposed the idea of regular intermittent napping as a countermeasure to desynchronosis. The technique has shown results with NASA’s Hubble aircraft with aircrew taking short naps in between to balance out their circadian cycles, and thus is being further proposed for commercial air travel as well.

Key Benefits of the Report

  • This study presents the analytical depiction of the desynchronosis treatment industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the desynchronosis treatment market share.
  • The current market is quantitatively analyzed to highlight the market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis depending on competitive intensity and how the competition will take shape in the coming years.

Questions Answered in Desynchronosis Treatment Report

  • Which are the leading players active in the desynchronosis treatment market?
  • How is each segment of the market expected to grow during the forecast period?
  • What are the adoption trends for the desynchronosis treatment market in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What are the impacts of COVID-19 in the industry?
  • What is desynchronosis treatment?
  • What is the desynchronosis treatment market prediction in the future?
  • What are the current trends and predicted trends?

Desynchronosis Treatment Market Report Highlights

Aspects Details
By Product
  • Prescription Drugs
  • Over-the-counter Drugs
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Vanda Pharmaceuticals Inc., Purdue Pharma L.P, Clinigen Group plc, Nature's Bounty, Jamieson Laboratories Ltd., Pfizer Inc., Eisai Co., Ltd., ALEXZA, NOW Foods, Jazz Pharmaceuticals, Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Desynchronosis Treatment Market

Global Opportunity Analysis and Industry Forecast, 2023-2032